Ulysses’ M&A and corporate experience includes private equity transactions (M&A and acquisition finance), other private and public M&A transactions, complex domestic and cross-border transactions, mergers, spin-offs, JVs and reorganisations. His finance practice focuses on advising lenders, borrowers and private equity sponsors on complex finance transactions, in particular acquisition, leveraged and syndicated financings as well as financings with manifold security.

Expertise includes advising:

• The Swiss Confederation on the CHF 9 billion loss protection guarantee granted to UBS Group in connection with its merger with Credit Suisse Group (2023)
• Lead counsel to Actelion Ltd, the largest European biopharma company in its USD 30 bn acquisition by Johnson & Johnson and the simultaneous demerger of its drug discovery and early clinical pipeline business into Idorsia Ltd. as well as the IPO of Idorsia Ltd
• Capvis and Partners Group in their buy-out of VAT Group AG, the market leader for vacuum valves, and subsequently VAT Group AG in the CHF 1.38 billion IPO on SIX Swiss Exchange in April 2016, at that time the largest IPO in Europe in 2016
• Partners Group in its acquisition first of a minority stake (2021) and then the majority (2022/2023) in the Swiss watch manufacturer Breitling
• Capvis in its acquisition of Schurter Holding AG, a leading manufacturer of components for low voltage safe power supplies, input systems and sophisticated overall electronic solutions, and several other acquisitions and exits of Swiss portfolio companies of Capvis (including Xovis, Variosystems and Lista)
• Founders and shareholders of Akara Group on the sale of the Swiss real estate asset manager Akara to Swiss Prime Site
• Columna Capital LLP in its acquisition of Ardentis, a leading Swiss dentist clinics group, and of Datamars SA, a leading Swiss supplier of identification solutions
• A consortium of more than 20 Swiss banks in a multibillion financing of a Swiss retail company